Nicotine dependence and lifetime amount of smoking in a population sample

European Journal of Public Health
Ulrich JohnHans-Jürgen Rumpf

Abstract

To determine how the age at starting smoking, any quit attempts and the single nicotine dependence criteria are related to the lifetime amount of smoking. A population-based sample of 4075 18 to 64-year-olds drawn at random in northern Germany was used. It included 836 former and 1601 current smokers. They were interviewed face-to-face at their homes with the Composite International Diagnostic Interview which provides a nicotine dependence diagnosis (DSM-IV). Also included was the Fagerström Test for Nicotine Dependence. The rates of smokers who started smoking at a young age, who had five or more quit attempts in the past and who fulfilled the single nicotine dependence criteria increased with the lifetime amount of tobacco smoked. Nicotine dependence may be a main impeding factor against efforts to decrease smoker rates.

Citations

Dec 19, 2009·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·W Kunstmann
May 14, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Timothy B BakerDale S Cannon
Jan 24, 2008·The American Journal of Dermatopathology·Noriyuki Misago
Jun 1, 2005·Tobacco Control·C P WenS P Tsai
May 5, 2010·Pediatrics·Chyke A DoubeniJoseph R Difranza
Aug 26, 2006·Addiction·John R Hughes
May 18, 2006·Drug and Alcohol Dependence·John R HughesSarah A Lindberg
May 5, 2005·Western Journal of Nursing Research·Monica S ScheibmeirByron Gajewski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.